These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8363777)

  • 21. Perspectives for a protective HIV-1 vaccine.
    Schiavone M; Quinto I; Scala G
    Adv Pharmacol; 2008; 56():423-52. PubMed ID: 18086420
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV/AIDS: allied responses.
    Mascola JR
    Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
    [No Abstract]   [Full Text] [Related]  

  • 25. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV: Bad news for stop--start therapy?
    McMichael AJ; Rowland-Jones SL
    Nature; 2002 Nov; 420(6914):371, 373. PubMed ID: 12459769
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune reconstitution in HIV-1-infected patients.
    Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.
    Musey LK; Krieger JN; Hughes JP; Schacker TW; Corey L; McElrath MJ
    J Infect Dis; 1999 Aug; 180(2):278-84. PubMed ID: 10395840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring HIV-1-specific T cell immunity: how valid are current assays?
    D'Souza MP; Altfeld M
    J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
    [No Abstract]   [Full Text] [Related]  

  • 31. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D; Elizaga M; Duerr A
    Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS vaccine development: the long and winding road.
    Garber DA; Feinberg MB
    AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immune control of HIV-infection and replication].
    Matsushita S
    Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-1 step study.
    White AM
    Lancet; 2009 Mar; 373(9666):805; author reply 806. PubMed ID: 19269505
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?
    Plummer FA; Ball TB; Kimani J; Fowke KR
    Immunol Lett; 1999 Mar; 66(1-3):27-34. PubMed ID: 10203031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basis of HIV resistance suggests new vaccine strategy.
    Senior K
    Lancet; 2001 May; 357(9268):1594. PubMed ID: 11377653
    [No Abstract]   [Full Text] [Related]  

  • 38. Proving HIV-1 immunity: new tools offer new opportunities.
    Picker LJ
    J Clin Invest; 2000 May; 105(10):1333-4. PubMed ID: 10811838
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immune response to human immunodeficiency virus in homosexual men.
    Ranki A
    J Infect Dis; 1993 Feb; 167(2):498. PubMed ID: 8421190
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV and the immune system.
    Rowe PM
    Lancet; 1994 Oct; 344(8929):1081. PubMed ID: 7934459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.